This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
07 Aug 2013  |  Latin America  |  Market Research
Global Pharmaceutical Contract Manufacturing Market
Injectable Dose Formulations will Likely Spur the Growth of CMOs
This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support se...
$12,000.00 -
30 Jul 2013  |  Europe  |  Technology Research
Top Technologies in Health and Wellness--2013 (Technical Insights)
Rewriting Life…
This research service offers an assessment for marketed and pipeline products for the global ACS therapeutics market. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are br...
$4,950.00 -
11 Jun 2013  |  Europe  |  Market Research
Importance of Long-term Storage of Clinical Samples
Smart Biobanking - Biobanking Community will Sense a Growing Need for Innovative Products in the Realm of Bio-Storage Applications
The world is seeing an outburst of disease-based regional and national biobanks for clinical research; as a result, good storage practices and standard operating procedures (SOPs) play a vital role in preserving decade-old samples. Complaint storage, sample shipment and data management procedures should be carefully considered to enable the formula...
$1,500.00 -
31 May 2013  |  Europe  |  Market Research
Global Point-of-Care Testing (POCT) Market
Increasing Adoption of POCT in Emerging Countries will Provide Impetus to Market Growth
Reduced turnaround time and potential benefits of immediate diagnosis have resulted in an increased adoption of POCT in hospitals and physician office laboratories. However, whether POC tests replace traditional laboratory tests is a question still being debated in the scientific community. This study provides the market overview, market engineerin...
$4,950.00 -
07 May 2013  |  Latin America  |  Market Research
2013 Europe; New Product Innovation - Extremolyte Therapeutics for Allergies
This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients ad...
$1,500.00 -
06 May 2013  |  Europe  |  Market Research
Healthcare Landscape and Outlook in Turkey
Top Growth Opportunities by 2015
The study analyses the Turkish healthcare landscape, market outlook and growth opportunities by covering private healthcare services, pharmaceuticals, medical devices, medical imaging and clinical diagnostics segments. Rapid economic growth and healthcare transformation program generated a significant increase in healthcare expenditure in Turkey. T...
$4,950.00 -
05 Apr 2013  |  Europe  |  Market Research
Market Trends in Interventional Radiology and Cardiology in Europe
The Future is in Hybrid Systems
This research service provides an analysis of various aspects of the interventional radiology and cardiology market in Europe between 2011 and 2017. The study covers twelve countries and regions: Benelux, Bulgaria, the Czech Republic, France, Germany, Hungary, Italy, Poland, Romania, Scandinavia, Spain and the United Kingdom. A detailed analysis of...
$4,950.00 -
28 Mar 2013  |  Latin America  |  Market Research
Brazilian Medical Imaging Market Outlook for CT, MRI, and Ultrasound
Governmental Programs and Investments Stimulate the Market
This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the C-class economic growth that allows increa...
$10,000.00 -
19 Mar 2013  |  Europe  |  Market Research
A Product and Pipeline Analysis of the Global Haematology Therapeutics Market
An Overview of Promising Drugs and Innovations in the Haematology Therapeutics Market
This market insight provides the list of key marketed products as well key compounds in phase 2 and 3 clinical trials in the global nonmalignant blood disorders market, classified into eight major segments including antianaemics, anticoagulants, antifibrinolytics, fibrinolytics, blood substitutes, plasma expanders, platelet aggregation inhibitors, ...
$1,500.00 -
12 Mar 2013  |  Europe  |  Market Research
Effective Strategies to Overcome Challenges Faced by Global Generic Drug Makers
Challenges Confronting Global Generic Drug Manufacturers
This article explains in detail the various challenges that confront the generic drug manufacturers in the global generic pharmaceuticals market. The defense strategies adopted by branded pharmaceutical companies to delay generic versions of their products have also been discussed. Strategic recommendations for the success of global generic compani...
$1,500.00